Physician profile
Justin Cooper
NPI 1316339385
$4,453.06
in general payments reported to CMS, 2019-2025
15 companies · $285 in 2025
The $285 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $98.01 · 2022: $116 · 2023: $3,768 · 2024: $186 · 2025: $285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,622 · Food and Beverage: $415 · Travel and Lodging: $126 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,622.14 |
| Food and Beverage | $415.47 |
| Travel and Lodging | $126.03 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $3,828.61 | 2022-2023 | |
| Janssen Biotech, INC. | $170.07 | 2025 | Carvykti, Rybrevant, Erleada |
| Ethicon US, LLC | $134.04 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $74.99 | 2024 | |
| Olympus America INC. | $66.58 | 2025 | Itind System |
| Genzyme Corporation | $26.84 | 2024 | |
| Baxter Healthcare | $23.81 | 2024 | Tisseel |
| Immunitybio, INC. | $22.81 | 2025 | |
| Agios Pharmaceuticals, INC. | $21.74 | 2024 | |
| Exelixis INC. | $20.27 | 2024 | Cabometyx |
| Endo USA, INC. | $19.47 | 2025 | Xiaflex, Aveed |
| Karyopharm Therapeutics INC. | $18.34 | 2024 | Xpovio |
| Axonics, INC. | $15.72 | 2021 | |
| Janssen Scientific Affairs, LLC | $5.95 | 2025 | Erleada |
| Travere Therapeutics, INC. | $3.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.